Foot and ankle allograft is a treatment that involves transplanting a cell or tissue from one person to another in order to save lives, reconstruct limbs, and relieve pain in patients. The donor should be non-identical, belonging to the same species as the recipient but with a different genotype. It's usually utilized to improve the patient's quality of life during the reconstructive process around the foot and ankle. Allografts are transplanted from one person to another and are commonly utilized in foot and ankle reconstructive operations. Osteochondral grafts, osseous/structural grafts, and allograft tendons are the three broad kinds of allografts.
This report contains market size and forecasts of Foot and Ankle Allograft in Global, including the following market information:
Global Foot and Ankle Allograft Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Foot and Ankle Allograft market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allograft Wedges Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Foot and Ankle Allograft include CONMED Corporation, Wright Medical Group NV, Arthrex, Integra LifeSciences, Smith+Nephew, Zimmer Biomet, AlloSource, Amniox Medical and RTI Surgical Holdings, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Foot and Ankle Allograft companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Foot and Ankle Allograft Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Foot and Ankle Allograft Market Segment Percentages, by Type, 2021 (%)
Allograft Wedges
Allograft Tendons
Allograft Acellular Dermal Matrix
Cartilage Allograft Matrix
Skin Allografts
Others
Global Foot and Ankle Allograft Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Foot and Ankle Allograft Market Segment Percentages, by Application, 2021 (%)
Hospitals
Orthopaedic Clinics
Ambulatory Surgical Centres
Others
Global Foot and Ankle Allograft Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Foot and Ankle Allograft Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Foot and Ankle Allograft revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Foot and Ankle Allograft revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CONMED Corporation
Wright Medical Group NV
Arthrex
Integra LifeSciences
Smith+Nephew
Zimmer Biomet
AlloSource
Amniox Medical
RTI Surgical Holdings
JRF Ortho
Musculoskeletal Transplant Foundation
Lattice Biologics
Össur
Acumed
Extremity Medical
MTF biologics
Johnson & Johnson Private Limited